Bristol-Myers Squibb

+$0.66 (+1.14%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BMY and other ETFs, options, and stocks.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics.

CEO

Giovanni Caforio

Employees

30,250

Headquarters

New York, New York

Founded

1933

BMY Key Statistics

Market Cap

129.68B

Price-Earnings Ratio

—

Dividend Yield

3.36

Average Volume

12.51M

High Today

$58.69

Low Today

$57.91

Open Price

$58.07

Volume

9.44M

52 Week High

$69.75

52 Week Low

$56.66

BMY News

BenzingaOct 12

Death Cross Looms Over Bristol-Myers Squibb Investors

If history is any guide, there may be trouble ahead for shares of Bristol-Myers Squibb(NYSE:BMY). A so-called "death cross" has formed on its chart and, not sur

Analyst Ratings

67%

of 21 ratings

Buy

66.7%

Hold

33.3%

Sell

BMY Earnings

$0.00

$0.64

$1.29

$1.93

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Available Oct 27, Pre-Market

Why Robinhood?

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. View more

Death Cross Looms Over Bristol-Myers Squibb Investors

67%

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics.